Abbas Yadegar

6.6k total citations · 1 hit paper
157 papers, 2.5k citations indexed

About

Abbas Yadegar is a scholar working on Surgery, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Abbas Yadegar has authored 157 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Surgery, 59 papers in Infectious Diseases and 47 papers in Molecular Biology. Recurrent topics in Abbas Yadegar's work include Helicobacter pylori-related gastroenterology studies (61 papers), Clostridium difficile and Clostridium perfringens research (42 papers) and Gut microbiota and health (31 papers). Abbas Yadegar is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (61 papers), Clostridium difficile and Clostridium perfringens research (42 papers) and Gut microbiota and health (31 papers). Abbas Yadegar collaborates with scholars based in Iran, Italy and United States. Abbas Yadegar's co-authors include Mohammad Reza Zali, Hamid Asadzadeh Aghdaei, Masoumeh Azimirad, Amir Sadeghi, Ali Nabavi-Rad, Shabnam Shahrokh, Hamed Mirjalali, Morteza Sattari, Sama Rezasoltani and Hedayatollah Ghourchian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Microbiology Reviews and Scientific Reports.

In The Last Decade

Abbas Yadegar

143 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fecal microbiota transplantation: current challenges and future landscapes

2024 134 citations Abbas Yadegar, Haggai Bar‐Yoseph et al. Clinical Microbiology Reviews profile →

Peers

Countries citing papers authored by Abbas Yadegar

Since Specialization

Citations

This map shows the geographic impact of Abbas Yadegar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abbas Yadegar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abbas Yadegar more than expected).

Fields of papers citing papers by Abbas Yadegar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abbas Yadegar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abbas Yadegar. The network helps show where Abbas Yadegar may publish in the future.

Co-authorship network of co-authors of Abbas Yadegar

This figure shows the co-authorship network connecting the top 25 collaborators of Abbas Yadegar. A scholar is included among the top collaborators of Abbas Yadegar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abbas Yadegar. Abbas Yadegar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pathogenic Potential of Invasive Mucosa‐Associated Klebsiella pneumoniae Isolates in Ulcerative Colitis: Characterization of Virulence Factors and Inflammatory Response 2025 ·Immunity Inflammation and Disease ·(unknown), Abbas Yadegar, Shabnam Shahrokh, Maryam Ebrahimi, Hamidreza Houri	0
2	The impact of a multi-species probiotic supplementation on clinical symptoms and biochemical factors in patients with irritable bowel syndrome: a randomised controlled trial 2025 ·Archives of Physiology and Biochemistry ·(unknown), Maryam Ebrahimi, (unknown), (unknown), Abbas Yadegar	0
3	Therapeutic Potential of Trolox and Its Synthetic Derivatives as Multifunctional Bioactive Molecules in Periodontal Disease Management 2025 ·Drug Development Research ·(unknown), (unknown), Elaheh Abdollahi, Abbas Yadegar, (unknown), (unknown), (unknown), Mehdi Valipour	0
4	Pasteurized form of a potential probiotic lactobacillus brevis IBRC-M10790 exerts anti-inflammatory effects on inflammatory bowel disease in vitro 2024 ·BMC Complementary Medicine and Therapies ·(unknown), Abbas Akhavan Sepahi, Abbas Yadegar, (unknown)	7
5	PPAR-γ agonist mitigates intestinal barrier dysfunction and inflammation induced by Clostridioides difficile SlpA in vitro 2024 ·Scientific Reports ·(unknown), Masoumeh Azimirad, (unknown), (unknown), Mohammad Reza Zali, Abbas Yadegar	4
6	Fecal microbiota transplantation: current challenges and future landscapes breakdown → 2024 ·Clinical Microbiology Reviews ·Abbas Yadegar, Haggai Bar‐Yoseph, Tanya Monaghan, Sepideh Pakpour, Andrea Severino, Ed J. Kuijper, Wiep Klaas Smits, Elisabeth M. Terveer, (unknown), Ali Nabavi-Rad, Javad Sadeghi, Giovanni Cammarota, Gianluca Ianiro, (unknown), (unknown), Karen Wong, Dina Kao	134
7	Prevalence of Campylobacter Species, Helicobacter pylori, Human Papillomavirus, and JC Polyomavirus in Patients with Colorectal Cancer in Iran 2024 ·Archives of Clinical Infectious Diseases ·(unknown), Ehsan Nazemalhosseini Mojarad, Hossein Dabiri, Sama Rezasoltani, Abbas Yadegar, (unknown), Ali Mojtahedi, Mohammad Javad Nasiri	0
8	Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights 2024 ·Life Sciences ·(unknown), (unknown), (unknown), (unknown), Mohammad Reza Zali, Abbas Yadegar	22
9	A reconstructed genome‐scale metabolic model of Helicobacter pylori for predicting putative drug targets in clarithromycin and rifampicin resistance conditions 2024 ·Helicobacter ·(unknown), Abbas Yadegar, Mohammad Hossein Karimi‐Jafari	0
10	Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives 2023 ·Gut Pathogens ·(unknown), Maryam Noori, Masoumeh Azimirad, Seyed Reza Mohebbi, Hamid Asadzadeh Aghdaei, Abbas Yadegar, Mohammad Reza Zali	23
11	Clostridioides difficile PCR ribotypes 001 and 084 can trigger autophagy process in human intestinal Caco-2 cells 2023 ·Microbial Pathogenesis ·Masoumeh Azimirad, Maryam Noori, (unknown), (unknown), Hamid Asadzadeh Aghdaei, Abbas Yadegar, Daniel J. Klionsky, Mohammad Reza Zali	1
12	Akkermansia muciniphila exerts immunomodulatory and anti-inflammatory effects on gliadin-stimulated THP-1 derived macrophages 2023 ·Scientific Reports ·(unknown), Nastaran Asri, Anna Sapone, Kaveh Baghaei, Abbas Yadegar, Davar Amani, Mohammad Rostami‐Nejad	23
13	The Gliadin Hydrolysis Capacity of B. longum, L. acidophilus, and L. plantarum and Their Protective Effects on Caco-2 Cells against Gliadin-Induced Inflammatory Responses 2023 ·Nutrients ·(unknown), Aurelio Seidita, Nastaran Asri, Masoumeh Azimirad, Abbas Yadegar, Somayeh Jahani‐Sherafat, Anousheh Sharifan, Pasquale Mansueto, Antonio Carroccio, Mohammad Rostami‐Nejad	5
14	A smart nanopaper sensor for optical diagnosis ofHelicobacter pyloriinfection 2023 ·Materials Advances ·(unknown), (unknown), Mohammad Ali Kiani, Hossein Yousefi, Daniel Horák, Uliana Kostiv, Ali Nabavi-Rad, Abbas Yadegar, (unknown), Hamed Golmohammadi	2
15	Evaluation of gut microbiota of iranian patients with celiac disease, non-celiac wheat sensitivity, and irritable bowel syndrome: are there any similarities? 2023 ·BMC Gastroenterology ·Kaveh Naseri, Hossein Dabiri, Meysam Olfatifar, Mohammad Amin Shahrbaf, Abbas Yadegar, (unknown), Amir Sadeghi, Saeede Saadati, Mohammad Rostami‐Nejad, Anil K. Verma, Mohammad Reza Zali	7
16	Synthesis, Characterization, and Evaluation of Anti-Helicobacter Activity of Chitosan and Pectin Microparticles Containing Zataria multiflora Extract In Vitro 2022 ·SHILAP Revista de lepidopterología ·(unknown), Mir Khalil Pirouzifard, Abbas Yadegar, (unknown), Behrooz Jannat, Masoumeh Moslemi	0
17	Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease 2020 ·International Journal of Molecular Sciences ·Shaghayegh Baradaran Ghavami, Abbas Yadegar, Hamid Asadzadeh Aghdaei, Dario Sorrentino, (unknown), (unknown), Masoumeh Azimirad, Hedieh Balaii, Shabnam Shahrokh, Mohammad Reza Zali	30
18	Sugar Codes Conjugated Alginate: An Innovative Platform to Make a Strategic Breakthrough in Simultaneous Prophylaxis of GERD and Helicobacter pylori Infection 2020 ·SHILAP Revista de lepidopterología ·(unknown), Abbas Yadegar, Saeed Balalaie, (unknown), Mohammad Reza Zali, Hidekazu Suzuki, Gert Fricker, Ismaeil Haririan	0
19	Effect of sub-MIC values of metronidazole, ciprofloxacin, and imipenem on the growth and toxin production in Clostridioides difficile. 2019 ·PubMed Central ·(unknown), Masoumeh Azimirad, (unknown), (unknown), Abbas Yadegar	1
20	Evaluation and Comparison of Antibacterial Effects of Alcoholic Extracts of Zataria multiflora Boiss Leaves, Flowers and Root on Methicillin-Resistant Staphylococcus aureus 2010 ·SHILAP Revista de lepidopterología ·Abbas Yadegar, Morteza Sattari, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact